Clinical Laserthermia Systems AB News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.11.21	CLS Again Releases TRANBERG® Sterile Disposable Products into the US Market (GlobeNewswire)
25.10.21	CLS Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors (GlobeNewswire)
15.10.21	CLS Exhibits MRI-Guided, Focal Laser Ablation System for Prostate Cancer at the 94th National Congress of the Italian Society of Urology (GlobeNewswire)
14.09.21	CLS Exhibits High Precision, Image-Guided Focal Laser Ablation System at the 73rd Congress of the German Society for Urology Conference (GlobeNewswire)
19.07.21	Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology” (GlobeNewswire)
12.07.21	CLS and Toronto General Hospital Resume Clinical Trial for Prostate Cancer as Company Receives Approval for Updated Sterilization Process by Health Canada (GlobeNewswire)
07.07.21	CLS and University Hospital Magdeburg Begin Study of MRI-Ultrasound, Fusion-Guided Focal Laser Ablation Treatments of Prostate Cancer (GlobeNewswire)
13.01.21	CLS Strengthens its Organization with New Employees in Key Positions for Continued Global Establishment (GlobeNewswire)
17.11.20	CLS and Toronto General Hospital Continue Clinical Trial Collaboration Regarding MRI-Guided Laser Ablation Treatment of Prostate Cancer (GlobeNewswire)
04.11.20	CLS Receives New CPT® Reimbursement Code Approval by American Medical Association for Ultrasound-Guided Focal Laser Ablation of Prostate Cancer (GlobeNewswire)
12.10.20	CLS and University Hospital Magdeburg launch clinical trial regarding focal laser ablation treatment of localized prostate cancer (GlobeNewswire)
29.09.20	CLS Americas Highlights High-Precision, Image-Guided Laser Ablation System for Prostate Tumours and Soft Tissues at FOCAL2020 Virtual Conference (GlobeNewswire)
24.08.20	CLS and Advanced Medical Systems Form Joint Venture Cooperation, Introducing the Innovative TRANBERG® Thermal Therapy System and imILT® in the Asia-Pacific Region (GlobeNewswire)
22.05.20	CLS Conducts In-Vivo Laser Ablation Studies for Neuro and Prostate using TRANBERG Thermal Therapy System with Thermoguide (GlobeNewswire)
29.04.20	CLS Granted New U.S. Patent Covering Unique, Non-Cooled, Diffuser-type Laser Ablation Applicator (GlobeNewswire)
03.04.20	CLS Obtains EU Approval for New Thermometry Software Product, ThermoGuide, also Obtains Approval for Updated EC Certificate for Complete TRANBERG System including the Software (GlobeNewswire)
18.03.20	University Hospital in Germany Evaluates CLS TRANBERG® \| Laser Thermal Therapy System for Minimally Invasive Treatment of Small Liver Metastases and Tumors (GlobeNewswire)
10.12.19	CLS Presents Image-Guided Laser Thermotherapy Enhancements at ESIR - European School of Interventional Radiology Conference (GlobeNewswire)
25.11.19	CLS Presents Image-Guided Laser Thermotherapy Enhancements at MedTech Investing Europe Conference in London, UK (GlobeNewswire)
17.10.19	Clinical Laserthermia Systems Americas Names Michael Magnani as Managing Director (GlobeNewswire)
08.10.19	Desert Medical Imaging Doctors Presented Interim Clinical Study Results of MR-guided FLA Treatment of MR-visible Prostate Cancer at AdMeTech 4th Global Summit (GlobeNewswire)
07.10.19	Toronto General Hospital Physicians Presented Interim Clinical Study Results for MR-guided FLA Treatment of Low-intermediate Risk Localized Prostate Cancer at AdMeTech 4th Global Summit (GlobeNewswire)
02.10.19	CLS Presents Poster on “Laser Thermal Therapy for Brain Metastases” at 9th Annual Brain Mets Congress in Marseille, France (GlobeNewswire)
14.06.19	Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Clinical Laserthermia Systems AB (B)

Aktien Top/Flop

Meistgelesene Nachrichten